Targeting obesity-related inflammation in skin cancer: molecular and epigenetic insights for cancer chemoprevention by dietary phytochemicals

doi:10.5246/jcps.2016.04.028

中国药学(英文版) ›› 2016, Vol. 25 ›› Issue (4): 235-249.DOI: 10.5246/jcps.2016.04.028

• 【传统中药和植物药的癌症预防专栏】 • 上一篇下一篇

Targeting obesity-related inflammation in skin cancer: molecular and epigenetic insights for cancer chemoprevention by dietary phytochemicals

Ximena Paredes-Gonzalez¹, Francisco Fuentes², Yaoping Lu³, Ah Ng Tony Kong^1*

1. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, USA
2. Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Casilla 306-22, Santiago, Chile
3. Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, USA

收稿日期:2015-12-31 修回日期:2016-01-15 出版日期:2016-04-21 发布日期:2016-02-26
通讯作者: Tel.: +848-455-6369, Fax: +732-455-3134, E-mail: KongT@pharmacy.rutgers.edu
基金资助:
Institutional funds; R01-CA118947 and R01-CA152826 from the National Cancer Institute (NCI), R01AT007065 from the National Center for Complementary and Alternative Medicines (NCCAM) and the Office of Dietary Supplements (ODS).

Targeting obesity-related inflammation in skin cancer: molecular and epigenetic insights for cancer chemoprevention by dietary phytochemicals

Ximena Paredes-Gonzalez¹, Francisco Fuentes², Yaoping Lu³, Ah Ng Tony Kong^1*

1. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, USA
2. Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Casilla 306-22, Santiago, Chile
3. Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, USA

Received:2015-12-31 Revised:2016-01-15 Online:2016-04-21 Published:2016-02-26
Contact: Tel.: +848-455-6369, Fax: +732-455-3134, E-mail: KongT@pharmacy.rutgers.edu
Supported by:
Institutional funds; R01-CA118947 and R01-CA152826 from the National Cancer Institute (NCI), R01AT007065 from the National Center for Complementary and Alternative Medicines (NCCAM) and the Office of Dietary Supplements (ODS).

摘要/Abstract

摘要：

Non-melanoma skin cancer (NMSC) is one of the most common cancers in the US, although the role of obesity in skin cancer remains unclear. In vivo studies have consistently demonstrated that obese mice challenged with UVB radiation show increased skin tumorigenesis in comparison with leaner control mice. Growing evidence suggests that enhanced inflammation, oxidative stress and impaired apoptosis may play important roles in the development of skin cancer. Interventions such as voluntary exercise and the surgical removal of parametrial fat have been demonstrated to be effective in reducing adipose tissue that may influence the development of skin cancer; however, these interventions are not achievable in all obese patients. Therefore, the use of dietary natural phytochemicals that may modify and reverse the deregulated molecular and epigenetic events related to obesity and cancer development might represent a potential therapeutic modality due to their potential efficacy and low toxicity. In this review, we aim to provide the molecular and epigenetic basis of the NMSC-obesity relationship and to highlight the potential anti-cancer chemopreventive benefits of dietary phytochemicals such as sulforaphane and epigallocatechin-3-gallate.

关键词: Chemoprevention, Epigenetics, Obesity, Non-melanoma skin cancer

Abstract:

Key words: Chemoprevention, Epigenetics, Obesity, Non-melanoma skin cancer

中图分类号:

R962

Supporting:

Ximena Paredes-Gonzalez, Francisco Fuentes, Yaoping Lu, Ah Ng Tony Kong. Targeting obesity-related inflammation in skin cancer: molecular and epigenetic insights for cancer chemoprevention by dietary phytochemicals[J]. 中国药学(英文版), 2016, 25(4): 235-249.

参考文献

[1] Schmitt, J.; Seidler, A.; Diepgen, T.L.; Bauer, A. Br. J. Dermatol. 2011, 164, 291-307.
[2] Paredes-Gonzalez, X.; Khor, T.O.; Shu, L.; Saw, C.L.L.; Kong, A.N.T.; Kong, A.N.T. Ed. CRC Press: 2013, 21-39.
[3] Calle, E.E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M.J. N. Engl. J. Med. 2003, 348, 1625-1638.
[4] Sergentanis, T.N.; Antoniadis, A.G.; Gogas, H.J.; Antonopoulos, C.N.; Adami, H.O.; Ekbom, A.; Petridou, E.T. Eur. J. Cancer. 2013, 49, 642-657.
[5] Tang, J.Y.; Henderson, M.T.; Hernandez-Boussard, T.; Kubo, J.; Desai, M.; Sims, S.T.; Aroda, V.; Thomas, F.; McTiernan, A.; Stefanick, M.L. Cancer Epidemiol. Biomarkers Prev. 2013, 22, 2412-2415.
[6] Black, H.S. Mutat. Res. 1998, 422, 185-190.
[7] Meeran, S.M.; Singh, T.; Nagy, T.R.; Katiyar, S.K. Toxicol. Appl. Pharmacol. 2009, 241, 303-310.
[8] Huang, S.; Rutkowsky, J.M.; Snodgrass, R.G.; Ono-Moore, K.D.; Schneider, D.A.; Newman, J.W.; Adams, S.H.; Hwang, D.H. J. Lipid. Res. 2012, 53, 2002-2013.
[9] Lu, Y.P.; Lou, Y.R.; Nolan, B.; Peng, Q.Y.; Xie, J.G.; Wagner, G.C.; Conney, A.H. Proc. Natl. Acad. Sci. USA. 2006, 103, 16301-16306.
[10] Lu, Y.P.; Lou, Y.R.; Bernard, J.J.; Peng, Q.Y.; Li, T.; Lin, Y.; Shih, W.J.; Nghiem, P.; Shapses, S.; Wagner, G.C.; Conney, A.H. Proc. Natl. Acad. Sci. USA. 2012, 109, 9065-9070.
[11] Tannenbaum, A. Ann. New York Acad. Sci. 1947, 49, 5-18.
[12] Adams, T.D.; Stroup, A.M.; Gress, R.E.; Adams, K.F.; Calle, E.E.; Smith, S.C.; Halverson, R.C.; Simper, S.C.; Hopkins, P.N.; Hunt, S.C. Obesity (Silver Spring). 2009, 17, 796-802.
[13] Fraga, M.F.; Herranz, M.; Espada, J.; Ballestar, E.; Paz, M.F.; Ropero, S.; Erkek, E.; Bozdogan, O.; Peinado, H.; Niveleau, A.; Mao, J.H.; Balmain, A.; Cano, A.; Esteller, M. Cancer Res. 2004, 64, 5527-5534.
[14] Pollak, M.N.; Schernhammer, E.S.; Hankinson, S.E. Nat. Rev. Cancer. 2004, 4, 505-518.
[15] Henegar, C.; Tordjman, J.; Achard, V.; Lacasa, D.; Cremer, I.; Guerre-Millo, M.; Poitou, C.; Basdevant, A.; Stich, V.; Viguerie, N.; Langin, D.; Bedossa, P.; Zucker, J.D.; Clement, K. Genome. Biol. 2008, 9, R14.
[16] Kuhn, C.; Hurwitz, S.A.; Kumar, M.G.; Cotton, J.; Spandau, D.F. Int. J. Cancer. 1999, 80, 431-438.
[17] Chuang, T.Y.; Lewis, D.A.; Spandau, D.F. Br. J. Dermatol. 2005, 153, 552-557.
[18] Home, P.D.; Kahn, S.E.; Jones, N.P.; Noronha, D.; Beck-Nielsen, H.; Viberti, G.; Group, A.S.; Committee, R.S. Diabetologia. 2010, 53, 1838-1845.
[19] Checkley, L.A.; Rho, O.; Angel, J.M.; Cho, J.; Blando, J.; Beltran, L.; Hursting, S.D.; DiGiovanni, J. Cancer Prev. Res (Phila). 2014, 7, 54-64.
[20] Shi, H.; Kokoeva, M.V.; Inouye, K.; Tzameli, I.; Yin, H.; Flier, J.S. J. Clin. Invest. 2006, 116, 3015-3025.
[21] Toubal, A.; Treuter, E.; Clement, K.; Venteclef, N. Trends Endocrinol. Metab. 2013, 24, 625-634.
[22] Fasshauer, M.; Paschke, R. Diabetologia. 2003, 46, 1594-1603.
[23] Hursting, S.D.; Berger, N.A. J. Clin. Oncol. 2010, 28, 4058-4065.
[24] Katiyar, S.K.; Meeran, S.M. Free Radic. Biol. Med. 2007, 42, 299-310.
[25] Sharma, S.D.; Katiyar, S.K. Toxicol. Appl. Pharmacol. 2010, 244, 328-335.
[26] Itoh, K.; Chiba, T.; Takahashi, S.; Ishii, T.; Igarashi, K.; Katoh, Y.; Oyake, T.; Hayashi, N.; Satoh, K.; Hatayama, I.; Yamamoto, M.; Nabeshima, Y. Biochem. Biophys. Res. Commun. 1997, 236, 313-322.
[27] Schafer, M.; Dutsch, S.; auf dem Keller, U.; Navid, F.; Schwarz, A.; Johnson, D.A.; Johnson, J.A.; Werner, S. Genes Dev. 2010, 24, 1045-1058.
[28] Xu, C.; Huang, M.T.; Shen, G.; Yuan, X.; Lin, W.; Khor, T.O.; Conney, A.H.; Kong, A.N.T. Cancer Res. 2006, 66, 8293-8296.
[29] Saw, C.L.; Huang, M.T.; Liu, Y.; Khor, T.O.; Conney, A.H.; Kong, A.N. Mol. Carcinog. 2011, 50, 479-486.
[30] Su, Z.Y.; Zhang, C.; Lee, J.H.; Shu, L.; Wu, T.Y.; Khor, T.O.; Conney, A.H.; Kong, A.N.; Lu, Y.P. Cancer Prev. Res (Phila). 2014, 456-465.
[31] Kim, Y.; Park, T. Biotechnol. J. 2010, 5, 99-112.
[32] Curtis, J.M.; Grimsrud, P.A.; Wright, W.S.; Xu, X.; Foncea, R.E.; Graham, D.W.; Brestoff, J.R.; Wiczer, B.M.; Ilkayeva, O.; Cianflone, K.; Muoio, D.E.; Arriaga, E.A.; Bernlohr, D.A. Diabetes. 2010, 59, 1132-1142.
[33] Seo, H.A.; Lee, I.K. Oxid. Med. Cell Longev. 2013, 2013, 184598.
[34] Chartoumpekis, D.V.; Kensler, T.W. Curr. Diabetes Rev. 2013, 9, 137-145.
[35] Rada, P.; Rojo, A.I.; Chowdhry, S.; McMahon, M.; Hayes, J.D.; Cuadrado, A. Mol. Cell. Biol. 2011, 31, 1121-1133.
[36] Lou, Y.R.; Peng, Q.Y.; Li, T.; Medvecky, C.M.; Lin, Y.; Shih, W.J.; Conney, A.H.; Shapses, S.; Wagner, G.C.; Lu, Y.P. Carcinogenesis. 2011, 32, 1078-1084.
[37] Lu, Y.P.; Lou, Y.R.; Lin, Y.; Shih, W.J.; Huang, M.T.; Yang, C.S.; Conney, A.H. Cancer Res. 2001, 61, 5002-5009.
[38] Pan, D.; Fujimoto, M.; Lopes, A.; Wang, Y.X. Cell. 2009, 137, 73-86.
[39] Dupont, J.; Fernandez, A.M.; Glackin, C.A.; Helman, L.; LeRoith, D. J. Biol. Chem. 2001, 276, 26699-26707.
[40] Liu, X.W.; Taube, M.E.; Jung, K.K.; Dong, Z.; Lee, Y.J.; Roshy, S.; Sloane, B.F.; Fridman, R.; Kim, H.R.C. Cancer Res. 2005, 65, 898-906.
[41] Rhee, J.S.; Diaz, R.; Korets, L.; Hodgson, J.G.; Coussens, L.M. Cancer Res. 2004, 64, 952-961.
[42] Meissburger, B.; Stachorski, L.; Roder, E.; Rudofsky, G.; Wolfrum, C. Diabetologia. 2011, 54, 1468-1479.
[43] Kralisch, S.; Klein, J.; Lossner, U.; Bluher, M.; Paschke, R.; Stumvoll, M.; Fasshauer, M. FEBS Lett. 2005, 579, 6417-6422.
[44] Duffy, M.J.; Duggan, C. Clin. Biochem. 2004, 37, 541-548.
[45] Maillard, C.; Jost, M.; Romer, M. U.; Brunner, N.; Houard, X.; Lejeune, A.; Munaut, C.; Bajou, K.; Melen, L.; Dano, K.; Carmeliet, P.; Fusenig, N.E.; Foidart, J.M.; Noel, A. Neoplasia. 2005, 7, 57-66.
[46] Michalska, M.; Iwan-Zietek, I.; Gnilka, W.; Dabrowiecki, S.; Goralczyk, B.; Goralczyk, K.; Drela, E.; Rosc, D. Adv. Clin. Exp. Med. 2013, 22, 801-807.
[47] Alessi, M.C.; Juhan-Vague, I. Arterioscler Thromb. Vasc. Biol. 2006, 26, 2200-2207.
[48] Lobo, S.M.D.V.; Quinto, B.M.R.; Oyama, L.; Nakamichi, R.; Ribeiro, A.B.; Zanella, M.T.; Dalboni, M.A.; Batista, M.C. Cytokine. 2012, 60, 150-156.
[49] Deshmane, S.L.; Kremlev, S.; Amini, S.; Sawaya, B.E. J. Interferon Cytokine Res. 2009, 29, 313-326.
[50] Monfrecola, G.; Gaudiello, F.; Cirillo, T.; Fabbrocini, G.; Balato, A.; Lembo, S. Clin. Exp. Dermatol. 2013, 38, 185-188.
[51] Cullberg, K.B.; Larsen, J.O.; Pedersen, S.B.; Richelsen, B. Nutr. Diabetes. 2014, 4, e113.
[52] Yeop Han, C.; Kargi, A.Y.; Omer, M.; Chan, C.K.; Wabitsch, M.; O'Brien, K.D.; Wight, T.N.; Chait, A. Diabetes. 2010, 59, 386-396.
[53] Suganami, T.; Nishida, J.; Ogawa, Y. Arterioscler Thromb. Vasc. Biol. 2005, 25, 2062-2068.
[54] Kanda, H.; Tateya, S.; Tamori, Y.; Kotani, K.; Hiasa, K.I.; Kitazawa, R.; Kitazawa, S.; Miyachi, H.; Maeda, S.; Egashira, K.; Kasuga, M. J. Clin. Invest. 2006, 116, 1494-1505.
[55] Puisieux, A.; Valsesia-Wittmann, S.; Ansieau, S. Br. J. Cancer. 2006, 94, 13-17.
[56] Maestro, R.; Dei Tos, A.P.; Hamamori, Y.; Krasnokutsky, S.; Sartorelli, V.; Kedes, L.; Doglioni, C.; Beach, D.H.; Hannon, G.J. Genes Dev. 1999, 13, 2207-2217.
[57] Qin, Q.; Xu, Y.; He, T.; Qin, C.; Xu, J. Cell Res. 2012, 22, 90-106.
[58] Su, Y.W.; Xie, T.X.; Sano, D.; Myers, J.N. PLoS One. 2011, 6, e19412.
[59] Kushiro, K.; Nunez, N.P. Clin. Exp. Metastasis. 2011, 28, 877-886.
[60] Kushiro, K.; Chu, R.A.; Verma, A.; Nunez, N.P. Cancer Microenviron. 2011, 5, 73-82.
[61] Dobrian, A.D. Front Endocrinol. (Lausanne). 2012, 3, 108.
[62] Pettersson, A.T.; Laurencikiene, J.; Mejhert, N.; Naslund, E.; Bouloumie, A.; Dahlman, I.; Arner, P.; Ryden, M. Diabetes. 2010, 59, 564-571.
[63] Pettersson, A.T.; Mejhert, N.; Jernas, M.; Carlsson, L.M.S.; Dahlman, I.; Laurencikiene, J.; Arner, P.; Ryden, M. J. Clin. Endocrinol. Metab. 2011, 96, 133-141.
[64] Floc’h, N.; Kolodziejski, J.; Akkari, L.; Simonin, Y.; Ansieau, S.; Puisieux, A.; Hibner, U.; Lassus, P. PLoS One. 2013, 8, e72490.
[65] Lavebratt, C.; Almgren, M.; Ekstrom, T.J. Int. J. Obes (Lond). 2012, 36, 757-765.
[66] Milagro, F.I.; Mansego, M.L.; De Miguel, C.; Martinez, J.A. Mol. Aspects. Med. 2013, 34, 782-812.
[67] Sathyanarayana, U.G.; Moore, A.Y.; Li, L.; Padar, A.; Majmudar, K.; Stastny, V.; Makarla, P.; Suzuki, M.; Minna, J.D.; Feng, Z.; Gazdar, A.F. Cancer Lett. 2007, 245, 112-120.
[68] Brown, V.L.; Harwood, C.A.; Crook, T.; Cronin, J.G.; Kelsell, D.P.; Proby, C.M. J. Invest. Dermatol. 2004, 122, 1284-1292.
[69] Nandakumar, V.; Vaid, M.; Tollefsbol, T.O.; Katiyar, S.K. Carcinogenesis. 2011, 32, 597-604.
[70] Fraga, M.F.; Ballestar, E.; Villar-Garea, A.; Boix-Chornet, M.; Espada, J.; Schotta, G.; Bonaldi, T.; Haydon, C.; Ropero, S.; Petrie, K.; Iyer, N. G.; Perez-Rosado, A.; Calvo, E.; Lopez, J.A.; Cano, A.; Calasanz, M.J.; Colomer, D.; Piris, M.A.; Ahn, N.; Imhof, A.; Caldas, C.; Jenuwein, T.; Esteller, M. Nat. Genet. 2005, 37, 391-400.
[71] Okamura, M.; Inagaki, T.; Tanaka, T.; Sakai, J. Organogenesis. 2010, 6, 24-32.
[72] Xu, X.; Su, S.; Barnes, V. A.; De Miguel, C.; Pollock, J.; Ownby, D.; Shi, H.; Zhu, H.; Snieder, H.; Wang, X. Epigenetics. 2013, 8, 522-533.
[73] Kamei, Y.; Suganami, T.; Ehara, T.; Kanai, S.; Hayashi, K.; Yamamoto, Y.; Miura, S.; Ezaki, O.; Okano, M.; Ogawa, Y. Obesity (Silver Spring, Md). 2010, 18, 314-321.
[74] Liu, Z.H.; Chen, L.L.; Deng, X.L.; Song, H.J.; Liao, Y.F.; Zeng, T.S.; Zheng, J.; Li, H.Q. J. Endocrinol. Invest. 2012, 35, 585-589.
[75] Cordero, P.; Campion, J.; Milagro, F.I.; Goyenechea, E.; Steemburgo, T.; Javierre, B.M.; Martinez, J.A. J. Physiol. Biochem. 2011, 67, 463-470.
[76] Lopez-Legarrea, P.; Mansego, M.L.; Zulet, M.A.; Martinez, J.A. J. Clin. Biochem. Nutr. 2013, 53, 139-144.
[77] Ezponda, T.; Popovic, R.; Shah, M.Y.; Martinez-Garcia, E.; Zheng, Y.; Min, D.J.; Will, C.; Neri, A.; Kelleher, N.L.; Yu, J.; Licht, J.D. Oncogene. 2013, 32, 2882-2890.
[78] Tili, E.; Michaille, J.J.; Croce, C.M. Immunol. Rev. 2013, 253, 167-184.
[79] Garofalo, M.; Condorelli, G. L.; Croce, C. M.; Condorelli, G. Cell Death Differ. 2009, 17, 200-208.
[80] Dziunycz, P.; Iotzova-Weiss, G.; Eloranta, J.J.; Lauchli, S.; Hafner, J.; French, L.E.; Hofbauer, G.F.L. J. Invest. Dermatol. 2010, 130, 2686-2689.
[81] Heneghan, H.M.; Miller, N.; McAnena, O.J.; O'Brien, T.; Kerin, M.J. J. Clin. Endocrinol. Metab. 2011, 96, e846-850.
[82] Chartoumpekis, D.V.; Zaravinos, A.; Ziros, P.G.; Iskrenova, R.P.; Psyrogiannis, A.I.; Kyriazopoulou, V.E.; Habeos, I.G. PLoS One. 2012, 7, e34872.
[83] Xie, H.; Lim, B.; Lodish, H.F. Diabetes. 2009, 58, 1050-1057.
[84] Philippidou, D.; Schmitt, M.; Moser, D.; Margue, C.; Nazarov, P.V.; Muller, A.; Vallar, L.; Nashan, D.; Behrmann, I.; Kreis, S. Cancer Res. 2010, 70, 4163-4173.
[85] Kutty, R.K.; Nagineni, C.N.; Samuel, W.; Vijayasarathy, C.; Jaworski, C.; Duncan, T.; Cameron, J.E.; Flemington, E.K.; Hooks, J.J.; Redmond, T.M. Mol. Vis. 2013, 19, 737-750.
[86] Shi, C.; Zhu, L.; Chen, X.; Gu, N.; Chen, L.; Zhu, L.; Yang, L.; Pang, L.; Guo, X.; Ji, C.; Zhang, C. J. Interferon. Cytokine. Res. 2014, 34, 342-348.
[87] Liao, Y.; Lonnerdal, B. PLoS One. 2010, 5, e12976.
[88] Wu, X.L.; Cheng, B.; Li, P.Y.; Huang, H.J.; Zhao, Q.; Dan, Z.L.; Tian, D.A.; Zhang, P. World J. Gastroenterol. 2013, 19 , 7758-7765.
[89] Amankwah, E.K.; Anegbe, E.; Park, H.; Pow-Sang, J.; Hakam, A.; Park, J.Y. Asian J. Androl. 2013, 15, 226-230.
[90] Chang, C.L.; Au, L.C.; Huang, S.W.; Fai Kwok, C.; Ho, L.T.; Juan, C.C. Endocrinology. 2011, 152, 384-393.
[91] Pecot, C.V.; Rupaimoole, R.; Yang, D.; Akbani, R.; Ivan, C.; Lu, C.; Wu, S.; Han, H.D.; Shah, M.Y.; Rodriguez-Aguayo, C.; Bottsford-Miller, J.; Liu, Y.; Kim, S.B.; Unruh, A.; Gonzalez-Villasana, V.; Huang, L.; Zand, B.; Moreno-Smith, M.; Mangala, L.S.; Taylor, M.; Dalton, H.J.; Sehgal, V.; Wen, Y.; Kang, Y.; Baggerly, K.A.; Lee, J.S.; Ram, P.T.; Ravoori, M.K.; Kundra, V.; Zhang, X.; Ali-Fehmi, R.; Gonzalez-Angulo, A.M.; Massion, P.P.; Calin, G.A.; Lopez-Berestein, G.; Zhang, W.; Sood, A.K. Nat. Commun. 2013, 4, 2427.
[92] Wiklund, E.D.; Bramsen, J.B.; Hulf, T.; Dyrskjot, L.; Ramanathan, R.; Hansen, T.B.; Villadsen, S.B.; Gao, S.; Ostenfeld, M.S.; Borre, M.; Peter, M.E.; Orntoft, T.F.; Kjems, J.; Clark, S.J. Int. J. Cancer. 2011, 128, 1327-1334.
[93] Ma, L.; Teruya-Feldstein, J.; Weinberg, R.A. Nature. 2007, 449, 682-688.
[94] Li, X.; Zhang, Y.; Zhang, H.; Liu, X.; Gong, T.; Li, M.; Sun, L.; Ji, G.; Shi, Y.; Han, Z.; Han, S.; Nie, Y.; Chen, X.; Zhao, Q.; Ding, J.; Wu, K.; Daiming, F. Mol. Cancer Res. 2011, 9, 824-833.
[95] Nairismagi, M.L.; Fuchtbauer, A.; Labouriau, R.; Bramsen, J.B.; Fuchtbauer, E.M. PLoS One. 2013, 8, e66070.
[96] Cheung, K.L.; Kong, A.N. AAPS J. 2010, 12, 87-97.
[97] Pham, N.A.; Jacobberger, J.W.; Schimmer, A.D.; Cao, P.; Gronda, M.; Hedley, D.W. Mol. Cancer Ther. 2004, 3, 1239-1248.
[98] Choi, K.M.; Lee, Y.S.; Kim, W.; Kim, S.J.; Shin, K.O.; Yu, J.Y.; Lee, M.K.; Lee, Y.M.; Hong, J.T.; Yun, Y.P.; Yoo, H.S. J. Nutr. Biochem. 2014, 25, 201-207.
[99] Lee, J.H.; Moon, M.H.; Jeong, J.K.; Park, Y.G.; Lee, Y.J.; Seol, J.W.; Park, S.Y. Biochem. Biophys. Res. Commun. 2012, 426, 492-497.
[100] Starrett, W.; Blake, D.J. J. Immunotoxicol. 2011, 8, 150-158.
[101] Moon, D.O.; Kim, M.O.; Kang, S.H.; Choi, Y.H.; Kim, G.Y. Cancer Lett. 2009, 274, 132-142.
[102] Hunakova, L.; Sedlakova, O.; Cholujova, D.; Gronesova, P.; Duraj, J.; Sedlak, J. Neoplasma. 2009, 56, 548-556.
[103] Hamsa, T.P.; Thejass, P.; Kuttan, G. Drug Chem. Toxicol. 2011, 34, 332-340.
[104] Saha, K.; Hornyak, T.J.; Eckert, R.L. AAPS J. 2013, 15, 1064-1071.
[105] Gerhauser, C. Curr. Opin. Clin. Nutr. Metab. Care. 2013, 16, 405-410.
[106] Balasubramanian, S.; Chew, Y.C.; Eckert, R.L. Mol. Pharmacol. 2011, 80, 870-878.
[107] Singh, B.N.; Shankar, S.; Srivastava, R.K. Biochem. Pharmacol. 2011, 82, 1807-1821.
[108] Mantena, S.K.; Meeran, S.M.; Elmets, C.A.; Katiyar, S.K. J. Nutr. 2005, 135, 2871-2877.
[109] Katiyar, S.K. Arch. Biochem. Biophys. 2011, 508, 152-158.
[110] Nandakumar, V.; Vaid, M.; Katiyar, S.K. Carcinogenesis. 2011, 32, 537-544.
[111] An, I.S.; An, S.; Park, S.; Lee, S.N.; Bae, S. Oncol. Rep. 2012, 29, 253-259.
[112] Moon, H.S.; Lee, H.G.; Choi, Y.J.; Kim, T.G.; Cho, C.S. Chem. Biol. Interact. 2007, 167, 85-98.
[113] Klaus, S.; Pultz, S.; Thone-Reineke, C.; Wolfram, S. Int. J. Obes (Lond). 2005, 29, 615-623.

Targeting obesity-related inflammation in skin cancer: molecular and epigenetic insights for cancer chemoprevention by dietary phytochemicals

Targeting obesity-related inflammation in skin cancer: molecular and epigenetic insights for cancer chemoprevention by dietary phytochemicals

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

[1]	Eric Wei Chiang Chan, Siu Kuin Wong, Hung Tuck Chan. An overview of Pu-erh tea and its health-promoting effects of lipid-lowering and anti-obesity[J]. 中国药学(英文版), 2021, 30(8): 623-633.
[2]	Asia Abed Al-Mahmood, Limin Shu, Hyuck Kim, Christina Ramirez, Douglas Pung, Yue Guo, Wenji Li, Ah-Ng Tony Kong. Prostate cancer and chemoprevention by natural dietary phytochemicals[J]. 中国药学(英文版), 2016, 25(9): 633-650.
[3]	Ah-Ng Tony Kong, Siwang Yu. Cancers chemoprevention by dietary phytochemicals and traditional Chinese medicines: epigenetics and cellular signaling pathways[J]. 中国药学(英文版), 2016, 25(4): 233-234.
[4]	Finna Setiawan, Elin Yulinah Sukandar, Sukrasno, Ketut Adnyana I. Activity of tamarindus indica pulp water extract in high carbohydrate diet rats as a treatment for obesity and insulin resistance[J]. 中国药学(英文版), 2016, 25(12): 892-897.
[5]	Sujit Nair, Ah-Ng Tony Kong. Pharmacometrics of nutraceutical sulforaphane and its implications in prostate cancer prevention[J]. 中国药学(英文版), 2016, 25(1): 12-22.